Low-dose CBD oil can now legally be sold over-the-counter but no relevant products are, as yet, approved. Picture: iStock
Low-dose CBD oil can now legally be sold over-the-counter but no relevant products are, as yet, approved. Picture: iStock

Byron company hopes to engage in cannabis oil trials

There is still work to be done before Australians will be able to access CBD (cannabis) oil over-the-counter at pharmacies.

But approval of this easier access to low-dose versions of the product, which came into effect on February 1, means manufacturers are looking to engage in lengthy approvals processes.

Matt Cantelo is the CEO of Australian Natural Therapeutics Group, which is moving its head office to Byron Bay and has a growing operation in the New England area.

Mr Cantelo stressed patients cannot currently access any form of CBD over-the-counter.

"You won't be able to for some time," he said.

He said there's no clear evidence as to whether low doses have any clinical efficacy and extensive trials will have to consider this.

"We've been researching low-dose CBD for some time," Mr Cantelo said.

"At the moment there's little evidence that CBD at low doses is effective for treating anything."

 

<< Byron-based medical cannabis group lands $92 million deal >>

<< Why a medical cannabis pioneer is moving to the North Coast >>

 

While COVID-19 has seen the acceleration of particular clinical trials, Mr Cantelo said they were looking at six months to two years before there were any clear results, "especially for conditions that require really extensive clinical trials".

The approval now in place means people could potentially access over-the-counter CBD oil doses of up 150mg a day.

Currently, patients with particular conditions can access much higher doses by way of a prescription.

Matt Cantelo is the founder and CEO of Australian Natural Therapeutic Group. The company, the first in NSW to be approved to manufacture medical cannabis products, is moving its headquarters from Sydney to the Byron Shire.
Matt Cantelo is the founder and CEO of Australian Natural Therapeutic Group. The company, the first in NSW to be approved to manufacture medical cannabis products, is moving its headquarters from Sydney to the Byron Shire.

Mr Cantelo said those who access the scheme now for severe conditions like seizure-related diseases would not likely be helped sufficiently by a low-dosage product.

"It's still unproven as to whether 150mg per day works on any conditions at all," he said.

"As an industry we have to put our money where our mouth is."

"ANTG is certainly doing this, a number of other companies will be doing that as well.

"We've been collating data from around the world for some time looking at all the various conditions."

He hopes ANTG can engage with clinical trials.

He said it was important for people to understand "the facts" around the current situation, after some news reports in recent days suggested CBD was already available over-the-counter.

Some pharmacies have had people now requesting a product that is not yet available, he said.



Supermarket warning: Fruit, veggie prices soar 30%

Premium Content Supermarket warning: Fruit, veggie prices soar 30%

Fruit and vegetable prices to soar as farm labour crisis bites

Pilot likely ‘spatially disorientated’ before fatal crash

Premium Content Pilot likely ‘spatially disorientated’ before fatal crash

Data showed big variations in rate of climb and descent

Revealed: The stars who became business giants

Premium Content Revealed: The stars who became business giants

Find out how these Gold Coasters became business heavyweights